Skip to main content

Table 4 IC50 (ÎĽM) for melphalan and melflufen, and melphalan/melflufen ratio in primary human lymphoma cells

From: In vitro and in vivo activity of melflufen (J1) in lymphoma

Patient no

IC50 melphalan (ÎĽM)

IC50 melflufen (ÎĽM)

Ratio

1

1.7

0.018

94

2

6.7

0.51

13

3

7.0

0.059

118

4

19

0.053

363

5

89

0.55

162

6

8.5

0.12

73

7

29

0.11

271

8

6.0

0.018

337

9

2.8

<0.01

278

10

0.73

0.0080

91

11

13

0.079

160

12

1.2

0.0027

455

13

31

0.080

388

14

NA

NA

NA

15

24

0.90

27

16

16

0.66

24

MEAN

8.4

0.078

108

  1. The potency difference between melphalan and melflufen was statistically significant (p < 0.001, paired 2-tailed t–test)